Supplementary Figure S1 from Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) Trial
crossref（2024）
摘要
Figure S1. Effect of Nicotinamide on the expressions of RUNX1 and RUNX3 in urethaneinduced mouse lung cancers and human lung cancer cell lines
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要